Klaus Baumann

6.9k citations
84 papers · 2.2k · 1 hit paper · h-index 22

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 2%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Peptidase Inhibition and Analysis
    • PARP inhibition in cancer therapy

Papers in

Klaus Baumann

77 papers receiving 2.1k citations

Hit Papers

Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study 2009 · 504 citations
5040+5+11Years since publication100200300400500

Peers

Klaus Baumann
Comparison fields: 5 of 107
  • Reproductive Medicine 424
  • Oncology 1.0k
  • Obstetrics and Gynecology 265
  • Cancer Research 247
  • Radiology, Nuclear Medicine and Imaging 325
Replace Sylvia Stadlmann with:
Sylvia Stadlmann Austria
Chiara Mignogna Italy
Hitoshi Niikura Japan
Ken‐Ichiro Yoshida Japan
Nilgün Kapucuoğlu Türkiye
Georg Pfeiler Austria
Seiya Sato Japan
Rosina T. Lis United States
Koichi Miwa Japan
Mauricio P. Pinto Chile
Klaus Baumann relative to Sylvia Stadlmann Austria Sylvia Stadlmann's profile →
Citations per field
00.5×6.5×
Sylvia Stadlmann · 1×
Citations per year

Countries citing papers authored by Klaus Baumann

Since Specialization
Citations

This map shows the geographic impact of Klaus Baumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Baumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Baumann more than expected).

Fields of papers citing papers by Klaus Baumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Baumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Baumann. The network helps show where Klaus Baumann may publish in the future.

Co-authors

The 25 scholars most cited alongside Klaus Baumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Klaus Baumann Line = papers co-authored together Klaus Baumann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study
Hit paper breakdown →
2009504
2 1998166
3 2011141
4 2015128
5 199993
6 201267
7 201467
8 201466
9 199351
10 201349
11 201444
12 201142
13 200939
14 197236
15 201333
16 201433
17 199532
18 200131
19 199830
20 201330

About Klaus Baumann

Klaus Baumann is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Obstetrics and Gynecology, having authored 84 papers that have together received 2.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (32 papers), Endometrial and Cervical Cancer Treatments (13 papers), Hormonal Regulation and Hypertension (10 papers), PARP inhibition in cancer therapy (7 papers), Cervical Cancer and HPV Research (7 papers), Renal cell carcinoma treatment (6 papers), Fatty Acid Research and Health (5 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Reproductive Medicine (424 citations), Oncology (1.0k citations), Obstetrics and Gynecology (265 citations), Cancer Research (247 citations) and Radiology, Nuclear Medicine and Imaging (325 citations). Klaus Baumann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Andreas du Bois, Gϋnter von Minckwitz, Sibylle Loibl, Nicolaì Maass, Tanja Čufer, Robert C. Stein, Christoph Zielinski, Marcus Schmidt, Felix E. de Jongh and Valentina Nekljudova. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology, International Journal of Gynecological Cancer and European Journal of Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact